Video Experimental Relacionado
Updated: Jan 29, 2026
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.8K
Desarrollo de inhibidores de PARP dirigidos a las mitocondrias
Pavels Dimitrijevs1, Marina Makrecka-Kuka1, Pavel Arsenyan1
1Latvian Institute of Organic Synthesis, Aizkraukles 21, LV1006 Riga, Latvia.
Biomolecules
|January 28, 2026
Resumen
Los investigadores desarrollaron nuevos inhibidores de PARP dirigidos a las mitocondrias mediante la conjugación de fármacos existentes con fosfonio. Estos nuevos compuestos muestran una mayor potencia contra las células de cáncer de mama con deficiencia de BRCA1 y mantienen la selectividad.
Área de la Ciencia:
- Oncología
- Química Medicinal
- Biología Mitocondrial
Sus antecedentes:
- Los inhibidores de la poli(ADP-ribosa) polimerasa (PARP) son fármacos anticancerígenos establecidos dirigidos a tumores con deficiencia de recombinación homóloga (HRD).
- La focalización de las mitocondrias para la acción de fármacos organelo-específicos sigue siendo un desafío.
- El desarrollo de inhibidores de PARP dirigidos a las mitocondrias podría mejorar la eficacia y superar la resistencia en cánceres HRD.
Objetivo del estudio:
- Diseñar y sintetizar nuevos inhibidores de PARP dirigidos a las mitocondrias.
- Evaluar su capacidad para acumularse selectivamente en las mitocondrias y modular la actividad de PARP.
- Evaluar su eficacia anticancerígena y selectividad.
Principales métodos:
- Síntesis de conjugados de trialquil(aril)fosfonio de olaparib y rucaparib.
- Evaluación de la inhibición de PARP1, la afinidad de unión a cardiolipina y la citotoxicidad en células de cáncer de mama con deficiencia de BRCA1 (HCC1937) y cardiomiocitos no malignos (H9C2).
Principales resultados:
- Los conjugados conservaron una potente inhibición de PARP1 (IC50 = 3,4-17 nM).
- Los derivados específicos (2d, 6c) mostraron una fuerte unión a cardiolipina y una mayor citotoxicidad en células HCC1937 (IC50 = 0,93, 2,01 µM), superando a los fármacos parentales.
- La reducción de la citotoxicidad en células H9C2 indicó un perfil de selectividad favorable.
Conclusiones:
- La conjugación con fosfonio confiere con éxito la focalización mitocondrial a los inhibidores de PARP.
- Los inhibidores de PARP dirigidos a las mitocondrias demuestran una mayor potencia y selectividad anticancerígena.
- Esta estrategia es prometedora para las terapias de próxima generación contra tumores con deficiencia de HR, lo que podría mejorar la eficacia y superar la resistencia.
Videos de Conceptos Relacionados
01:30Peroxisomes and Mitochondria
95.2K
Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
95.2K
01:37Mitochondria
20.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.4K
01:52Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
01:19Translocation of Proteins into the Mitochondria
13.4K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.4K
01:23Dipeptidyl Peptidase 4 Inhibitors
644
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
644
01:43Sustainable Development
15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K